The Impact of Oncotype DX in invasive lobular carcinoma of the breast: An institutional experience

被引：0
|
作者：
McGreevy, Christopher [1 ]
Mateo, Alina [1 ]
De La Cruz, Lucy [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581766
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [21] Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer
    Gunthner-Biller, M.
    Stempel, M.
    Patil, S.
    King, T.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S68 - S68
  • [22] Oncotype DX Testing Does Not Benefit Patients with Low-Grade Breast Invasive Carcinoma
    Hou, Yanjun
    Zynger, Debra L.
    Li, Zaibo
    LABORATORY INVESTIGATION, 2017, 97 : 47A - 47A
  • [23] Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer
    Maria Karsten
    Michelle Stempel
    Julia Radosa
    Sujata Patil
    Tari A. King
    Annals of Surgical Oncology, 2016, 23 : 471 - 476
  • [24] Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer
    Karsten, Maria
    Stempel, Michelle
    Radosa, Julia
    Patil, Sujata
    King, Tari A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (02) : 471 - 476
  • [25] The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
    Crolley, Valerie E.
    Marashi, Husam
    Rawther, Shabbir
    Sirohi, Bhawna
    Parton, Marina
    Graham, Janine
    Vinayan, Anup
    Sutherland, Stephanie
    Rigg, Anne
    Wadhawan, Anshu
    Harper-Wynne, Catherine
    Spurrell, Emma
    Bond, Hannah
    Raja, Fharat
    King, Judy
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 809 - 817
  • [26] The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
    Valerie E. Crolley
    Husam Marashi
    Shabbir Rawther
    Bhawna Sirohi
    Marina Parton
    Janine Graham
    Anup Vinayan
    Stephanie Sutherland
    Anne Rigg
    Anshu Wadhawan
    Catherine Harper-Wynne
    Emma Spurrell
    Hannah Bond
    Fharat Raja
    Judy King
    Breast Cancer Research and Treatment, 2020, 180 : 809 - 817
  • [27] Oncotype DX Testing Does Not Benefit Patients with Low-Grade Breast Invasive Carcinoma
    Hou, Yanjun
    Zynger, Debra L.
    Li, Zaibo
    MODERN PATHOLOGY, 2017, 30 : 47A - 47A
  • [28] The Impact of Oncotype DX Breast Cancer Assay Results on Clinical Practice - a UK Experience
    Crolley, V.
    Rawther, S.
    Chaabouni, N.
    Rigg, A.
    Wadhawan, A.
    King, J.
    CLINICAL ONCOLOGY, 2017, 29 (06) : E98 - E99
  • [29] The impact of Oncotype DX breast cancer assay results on clinical practice: A UK experience
    Crolley, V. E.
    Marashi, H.
    Rawther, S. K. R.
    Parton, M.
    Graham, J.
    Vinayan, A.
    Sutherland, S.
    Rigg, A.
    Wadhawan, A.
    Harper-Wynne, C.
    Spurrell, E.
    Bond, H.
    Raja, F.
    King, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
    Crolley, Valerie E.
    Marashi, Husam
    Rawther, Shabbir Khan Rajan
    Sirohi, Bhawna
    Parton, Marina
    Graham, Janine
    Vinayan, Anup
    Sutherland, Stephanie
    Rigg, Anne
    Wadhawan, Anshu
    Harper-Wynne, Catherine
    Spurrell, Emma
    Bond, Hannah
    Raja, Fharat
    King, Judy
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 557 - 558
12345